Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | CNR2 | P34972 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7145613 | 0.96 | KMT2A (0.64) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL10627200 | 0.86 | KMT2A (0.53) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL9828649 | 0.86 | KMT2A (0.53) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL16415854 | 0.86 | KMT2A (0.53) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL27825425 | 0.86 | KMT2A (0.53) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL11454469 | 0.86 | CNR2 (0.58) | KMT2ACNR2ALDH1A1TDP1ATM | |
| SCHEMBL11398480 | 0.82 | KMT2A (0.50) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL20412771 | 0.81 | KMT2A (0.68) | KMT2ACNR2TDP1KDM4EALOX15 | |
| SCHEMBL11064851 | 0.81 | KMT2A (0.49) | KMT2ACNR2ALDH1A1TDP1TSHR | |
| SCHEMBL9299025 | 0.81 | CNR2 (0.49) | KMT2ACNR2ALDH1A1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539341-B | Rare earth complex doped DNA crystal for detecting medicine and preparation method and application thereof | 青岛大学 | 2023-12-01 | — | — | CN | claimed |
| CN-114539341-A | Rare earth complex doped DNA crystal for detecting medicine and preparation method and application thereof | 青岛大学 | 2022-05-27 | — | — | CN | claimed |
| JP-1188526-A | — | — | None | — | — | JP | disclosed |
| US-12258358-B1 | Ferrocene-substituted organometallic complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2024086607-A1 | FERROCENE-SUBSTITUTED ORGANOMETALLIC COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-114539341-B | Rare earth complex doped DNA crystal for detecting medicine and preparation method and application thereof | 青岛大学 | 2023-12-01 | — | — | CN | disclosed |
| CN-116199621-A | Synthesis method of chiral pyridine-2, 6-diol | 中国科学院大连化学物理研究所 | 2023-06-02 | — | — | CN | disclosed |
| CN-114539341-A | Rare earth complex doped DNA crystal for detecting medicine and preparation method and application thereof | 青岛大学 | 2022-05-27 | — | — | CN | disclosed |
| US-11193082-B2 | Wax isomerized oil | ENEOS CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| CN-107406546-B | Process for producing oligomer and catalyst | JXTG能源株式会社 | 2021-02-19 | — | — | CN | disclosed |
| US-20210032550-A1 | METHOD FOR PRODUCING WAX ISOMERIZED OIL | ENEOS CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| WO-2002000339-A2 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR ETHYLENE OLIGOMERISATION TO LINEAR ALPHA OLEFINS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2002-01-03 | — | — | WO | disclosed |
| EP-1125928-A9 | TRANSITION METAL COMPOUNDS, CATALYSTS FOR THE PRODUCTION OF ALPHA-OLEFINS AND PROCESS THEREFOR | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2001-11-14 | — | — | EP | disclosed |
| CN-1321111-A | Transition metal catalyst and preparation of polymer of alpha-olefin and vinyl compound | IDEMITSU PETROCHEMICAL CO (JP) | 2001-11-07 | — | — | CN | disclosed |
| EP-1136122-A1 | TRANSITION METAL CATALYSTS AND PROCESSES FOR PRODUCING $g(a)-OLEFIN AND VINYL COMPOUND POLYMER | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-1125928-A1 | TRANSITION METAL COMPOUNDS, CATALYSTS FOR THE PRODUCTION OF ALPHA-OLEFINS AND PROCESS THEREFOR | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2001-08-22 | — | — | EP | disclosed |
| WO-2001023396-A1 | POLYMERISATION CATALYST | BP CHEMICALS LIMITED (GB) | 2001-04-05 | — | — | WO | disclosed |
| WO-2001000686-A1 | METHOD FOR COPOLYMERIZING POLAR AND NON-POLAR MONOMERS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | disclosed |
| EP-1044992-A1 | Catalytic system for the polymerisation of olefin | Bayer Aktiengesellschaft (DE) | 2000-10-18 | — | — | EP | disclosed |
| JP-H01188526-A | NOVEL POLYCONDENSATION PRODUCT AND PRODUCTION THEREOF | N O K SOGO GIJUTSU KENKYUSHO:KK | 1989-07-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12258358-B1 | Ferrocene-substituted organometallic complexes | FECH, NDUFS4, NDUFS8 | KMT2A 2045/4885CNR2 3503/4885ALDH1A1 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.